Parasite Drug Shows Effectiveness Against Mesothelioma
Dr. Antonio Giordano believes his team has cleared the path to the next breakthrough in the treatment of malignant pleural mesothelioma. The advancement involves a new use for an old drug, pyrvinium pamoate, which doctors have successfully used for more than 50 years to treat infections of pinworm parasite. “This drug that no one expected to be involved with mesothelioma is potentially a new weapon against this aggressive type of tumor,” Giordano told Asbestos.com. “Our findings are exciting, very exciting. This one can move forward.” Giordano is the founder and director of the Sbarro Health Research Organization (SHRO) at Temple University in Philadelphia. He also is an internationally renowned professor of pathology and oncology at the University of Sienna in Italy. His expertise involves identifying novel targets and therapies at the molecular level. This particular drug has shown promise with mesothelioma as well as pancreatic and breast cancer. Better Mesothelioma Treatments Needed The findings have been published in the latest issue of Journal of Cell Physiology. A summary is available on the SHRO website. “This should trigger interest and attention of oncologists all over the world to work on it,” Giordano said. “It’s now about taking the initiative to bring this drug to the clinical bedside, to the patients.” Pleural mesothelioma, which is caused by exposure to asbestos, is a rare and aggressive cancer with no defi...
Pei-Li Zhu, Xiu-Qiong Fu, Jun-Kui Li, Anfernee Kai-Wing Tse, Hui Guo, Cheng-Le Yin, Ji-Yao Chou, Ya-Ping Wang, Yu-Xi Liu, Ying-Jie Chen, Muhammad Jahangir Hossen, Yi Zhang, Si-Yuan Pan, Zong-Jie Zhao, Zhi-Ling Yu
Kelvin M. Jones, Balasubramanyam Karanam, Jacqueline Jones-Triche, Maninder Sandey, Henry J. Henderson, Rajeev S. Samant, Samuel Temesgen, Clayton Yates, Deepa Bedi
Marie-France Penet, Balaji Krishnamachary, Flonn é B. Wildes, Yelena Mironchik, Chien-Fu Hung, TC Wu, Zaver M. Bhujwalla
Dr. Susan Slovin discusses how the evolution of therapeutic treatment is occurring in advanced stage prostate cancer Author: vhsimons Added: 12/17/2018
The concept of Precision Therapy in Prostate Cancer treatment will need to rely more heavily on genetic testing Author: vhsimons Added: 12/17/2018
Jiyan Su, Dan Li, Qianjun Chen, Muxia Li, Lu Su, Ting Luo, Danling Liang, Guoxiao Lai, Ou Shuai, Chunwei Jiao, Qingping Wu, Yizhen Xie, Xinxin Zhou
Juan P. Mu ñoz, Diego Carrillo-Beltrán, Víctor Aedo-Aguilera, Gloria M. Calaf, Oscar León, Edio Maldonado, Julio C. Tapia, Enrique Boccardo, Michelle A. Ozbun, Francisco Aguayo
Org. Biomol. Chem., 2018, Accepted Manuscript DOI: 10.1039/C8OB02668H, PaperYong qiang Zhu, Meng Lei, Huayun Feng, Enhe Bai, Hui Zhou, Jia Wang, Yan ru Qin, Hao yang Zhang, Xueyuan Wang, Zhaogang Liu, Ou Hai, Jia Liu A series of novel dipeptidyl boronic acid compounds were designed, synthesized and biologically investigated the inhibition of β5 subunit of 20S proteasome and several compounds showed high activities with the... The content of this RSS Feed (c) The Royal Society of Chemistry
Jun Wang, Zhen-Yu He, Yong Dong, Jia-Yuan Sun, Wen-Wen Zhang, San-Gang Wu
(University of Southern Denmark) Hope for better understanding of the inner works of cancer and other serious diseases.
More News: Asbestosis | Breast Cancer | Cancer | Cancer & Oncology | Cancer Therapy | Chemotherapy | Enterobiasis | Environmental Health | Genetics | Immunotherapy | Italy Health | Laboratory Medicine | Mesothelioma | Pancreas | Pancreatic Cancer | Parasitic Diseases | Parasitology | Pathology | Physiology | Study | Websites